Commercial Excellence

At a glance

Baker Tilly helps life sciences and healthcare companies focus on the right capabilities and the right customer experiences to facilitate the right growth.

Focusing on the intersection where strategy meets execution, Baker Tilly helps companies design and plan customer-centric strategies to address their overarching business objectives. Our team members’ deep experience in the life sciences and healthcare industries provides clients with the expertise needed to effectively align and strengthen their commercial planning and go-to-market strategies.

Pharmaceutical and other life sciences companies face major disruptions to the healthcare environment and care-delivery payment practices. The line between traditional commercial execution and real world evidence is fading. A shifting multi-customer environment with divergent demands for achieving economic outcomes and a movement from fee-for-service to risk sharing cost models are causing marketplace disruptions across pharma and medical device companies. As a result, companies are reexamining how they prepare for and execute their go-to-market strategies.

Baker Tilly professionals work with life sciences companies to address the market dynamics resulting from a more customer-driven approach to healthcare, helping them:

  • Optimize growth for new and in-line brands
  • Develop efficiencies across functional areas to transform operational effectiveness
  • Produce strategy to execution solutions to achieve expected results

Our experience includes helping emerging life sciences companies develop their go-to-market and market access strategies, as well as helping established companies reinvigorate under-performing brands, expand access and utilization with payer and provider organizations, expand customer channels through innovative economic modeling, develop risk-sharing contracting strategies and create value-based dossiers and communications. Our commercial excellence expertise encompasses many areas, including:

  • Self-insured employer customer channel access strategy, contracting and innovation – optimizing self-insured payers as primary customers
  • Post-launch growth optimization strategy and innovation – to reinvigorate and expand growth
  • Product-start-up and commercialization planning - using Product Opportunity Evaluation Modeling (POEM)

Whether the challenge is launching an entirely new product, relaunching an existing product or establishing a new division within the company, we can help companies build their strategies for validation and launch and expand market share and customer community.

By the numbers

400

Baker Tilly serves nearly 400 life sciences companies across the country